Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rHuPH20 with Humalog and Humulin R in Type 1 Diabetes
NCT00774800Phase 2Completed
- Sponsor
- Halozyme Therapeutics, Inc.
- Start
- Oct 2008
- Primary completion
- Mar 2009
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of hyaluronidase in type 1 diabetes mellitus (T1D), sponsored by Halozyme Therapeutics, Inc.. Started Oct 2008; status: completed.
02
Drugs
hyaluronidase
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00774800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00774800.